Mitral regurgitation stages

Jump to navigation Jump to search


Resident
Survival
Guide

Mitral Regurgitation Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Mitral Regurgitation from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

Stages

History and Symptoms

Physical Examination

Chest X Ray

Electrocardiogram

Echocardiography

Cardiac MRI

Cardiac Catheterization

Treatment

Overview

Acute Mitral Regurgitation Treatment

Chronic Mitral Regurgitation Treatment

Surgery

Follow Up

Case Studies

Case #1

Mitral regurgitation stages On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mitral regurgitation stages

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onMitral regurgitation stages

CDC on Mitral regurgitation stages

Mitral regurgitation stages in the news

Blogs on Mitral regurgitation stages

Directions to Hospitals Treating Mitral regurgitation

Risk calculators and risk factors for Mitral regurgitation stages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Twinkle Singh, M.B.B.S. [2]

Primary Mitral Regurgitation

Stages of Primary Mitral Regurgitation

Shown below is the able depicting stages of mitral regurgitation, adapted from 2014 AHA/ACC guidelines for management of valvular heart disease.[1]

STAGE DEFINITION VALVE ANATOMY VALVE HEMODYNAMICS HEMODYNAMIC CONSEQUENCES SYMPTOMS
A At risk of MR ❑ Mild MVP, normal coaptation
❑ Mild valve thickening with leaflet restriction
❑ No MR jet area OR
❑ Central jet area < 20% LA on doppler
❑ Small vena contracta <0.3 cm
None None
B Progressive MR ❑ Severe MVP, normal coaptation
❑ Rheumatic valve changes with leaflet restriction,
loss of central coaptation
❑ Prior IE
❑ Central jet area 20-40% LA OR
late systolic eccentric jet MR
❑ Vena contracta < 0.7 cm
❑ Regurgitant volume < 60 ml
❑ Regurgitant fraction <50 %
❑ ERO <0.40 cm2
❑ Angiographic grade 1 - 2+
❑ Mild LA enlargement
❑ No LV enlargement
❑ Normal pulmonary pressure
None
C Asymptomatic severe MR ❑ Severe MVP, flail leaflet
❑ Rheumatic valve changes with leaflet restriction,
loss of central coaptation
❑ Prior IE

❑ Thickening of leaflets in case of radiation heart disease

❑ Central jet area > 40% LA OR
holosystolic eccentric jet MR
❑ Vena contracta ≥ 0.7 cm
❑ Regurgitant volume ≥ 60 ml
❑ Regurgitant fraction ≥50 %
❑ ERO ≥0.40 cm2
❑ Angiographic grade 3 - 4+
❑ Moderate to severe LA enlargement
❑ LV enlargement
Pulmonary hypertension present at rest or with exercise
C1: LVEF > 60% and LVESD < 40 mm
C2: LVEF ≤ 60 % and LVESD ≥ 40 mm
None
D Symptomatic severe MR ❑ Severe MVP, flail leaflet
❑ Rheumatic valve changes with leaflet restriction,
loss of central coaptation
❑ Prior IE

❑ Thickening of leaflets in case of radiation heart disease

❑ Central jet area >40% LA OR
holosystolic eccentric jet MR
❑ Vena contracta ≥ 0.7 cm
❑ Regurgitant volume ≥ 60 ml
❑ Regurgitant fraction ≥ 50 %
❑ ERO ≥0.40 cm2
❑ Angiographic grade 3 - 4+
❑ Moderate to severe LA enlargement
❑ LV enlargement
Pulmonary hypertension present
❑ Decreased exercise tolerance
Exertional dyspnea

MR: Mitral regurgitation; MVP: Mitral valve prolapse; IE: Infective endocarditis; LA: Left atrium; ERO: Effective regurgitant orifice; LV: Left ventricle; LVEF: Left ventricular ejection fraction; LVESD: Left ventricular end systolic dimension

References

  1. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0000000000000029. PMID 24589852.

Template:WH Template:WS